Souhaitez-vous accéder aux communiqués récents ?

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...

The new ETP provides liquid access to JitoSOL, combining full Solana price exposure with a dual-source staking yield Zurich, 29 January 2026 — 21shares, one of the world’s largest issuers of...

Sampo Oyj, lehdistötiedote, 29.1.2026 klo 10.00 Sampo-konsernin tulos vuodelta 2025 julkaistaan 5.2.2026 Sampo-konsernin tilinpäätöstiedote vuodelta 2025 julkaistaan 5.2. noin klo 8.30. Raportti ja...

Sampo plc, press release, 29 January 2026 at 10:00 am EET Sampo Group's results for 2025 will be published on 5 February 2026 Sampo Group will publish the Financial Statement Release for 2025 on 5...

LEI: 213800NNT42FFIZB1T09  29 January 2026 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital...

ENDEAVOUR ACHIEVES GUIDANCE & DECLARES RECORD H2-2025 DIVIDENDFY-2025 production of 1,209koz at AISC of ~1,435/oz l H2-2025 dividend of $200m l >$1bn shareholder returns programme OPERATIONAL...

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN...

OXFORD, United Kingdom, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a...